We discovered that the main pathways of QGD against osteosarcoma were the PI3K-Akt signaling pathway, proteoglycans in cancer, MAPK signaling pathway, chemical carcinogenesis receptor activation pathway, cell aging, IL-17 signaling pathway, and EGFR tyrosine kinase inhibitor resistance. This evidence concerns the gene AKT1 and osteosarcoma.